Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Rethinking drug efficacy: research aims to improve drug development

    ... build on this work by applying the approach to different therapeutic areas and exploring the implications for drug formulation and ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ...

    sommers - 03/11/2024 - 8:54am

  2. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.   The drug is an allosteric ... The FDA then reviews all submitted data. If approved, the therapeutic will be made available for use by the public and be monitored for ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  3. Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye

    ... have identified levocarnitine as a novel potential therapeutic for treating this condition.   Addressed Need ... provide only temporary relief from symptoms. The proposed technology of oral levocarnitine administration offers a novel approach for ...

    cttc_admin - 02/15/2024 - 1:31pm

  4. Anti-inflammatory microparticles for sustained ocular drug delivery

    ... cargos in the eye for at least 6 weeks while also playing a therapeutic role in reducing inflammation. Addressed Need ... gold standard poly(lactic-co-glycolic acid) (PLGA). Technology Description To overcome these challenges, Vanderbilt ...

    cttc_admin - 02/01/2024 - 12:21pm

  5. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... that activating immune cells with this method may improve therapeutic efficacy and reduce manufacturing expenses.   ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  6. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... A cell-penetrating, anti-inflammatory peptide developed by  Jacek Hawiger , Louise B. McGavock Chair and ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ...

    sommers - 10/30/2020 - 12:45pm

  7. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... cover specific predictive biomarkers that cover a range of therapeutic classes.   Emanuel Petricoin, Ph.D., Chair of Theralink’s ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  8. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... project is now exploiting an antisense microRNA (anti-miR) therapeutic strategy directed to the inhibition of either one or two target ...

    steelmk - 11/15/2016 - 2:29pm

  9. Early effort to thwart chikungunya infection shows positive results

    ... To protect it, the Moderna team encapsulated it in a lipid nanoparticle using in their proprietary technology. Pre-clinical studies suggested that once injected, cells will take ... study shows for the first time the ability to generate therapeutic levels of a complex protein in humans through systemic ...

    sommers - 09/27/2019 - 9:55am

  10. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 03/25/2024 - 3:02pm